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INTRODUCTION
Blood pressure (BP) self-monitoring is an 
increasingly common and accepted activity 
for patients with hypertension, and is usually 
undertaken in the home.1 Meta-analyses of 
trial data suggest that, after training and 
as part of an ongoing management plan, 
self-monitoring leads to clinically significant 
reductions in BP2 and improved medication 
adherence.3 Qualitative studies describe how 
self-monitoring empowers patients, enabling 
them to better understand their condition,4 
although patients need clinician support 
and education regarding how to interpret 
results and when to seek assistance.4,5 Some 
clinicians have also expressed concerns 
about the potential for bias by patients when 
reporting self-monitoring data,6 and the 
accuracy of unsupervised measurements7 
taken on potentially uncalibrated monitors.8
BP self-screening whereby members 
of the public check their own BP using 
open-access monitors9 is now possible 
with the development of easy-to-use, 
clinically validated automatic solid-cuff 
sphygmomanometers.10,11 This type of cuff 
does not require fitting by a healthcare 
professional (HCP) and therefore such 
monitors can be utilised by lay people 
following simple instructions without training 
or supervision. BP self-screening offers 
the opportunity for BP measurements to 
be made outside their traditional setting 
of healthcare consultations. It is estimated 
that BP self-screening kiosks in the US — 
typically found in pharmacies and work sites 
— are used over a million times a day.12 It 
has been suggested that the presence of 
self-screening stations reduces undiagnosed 
hypertension and improves treatment rates.9
A recent systematic review9 identified 
three studies of self-screening: a UK 
pilot study of BP monitors in community 
settings;13 a Canadian study that extracted 
the data from BP self-screening kiosks in 341 
pharmacies;14 and a study of self-screening 
kiosks in US pharmacies and grocery 
stores.15 Patient experience was investigated 
in the UK study only. Thirty structured 
interviews were undertaken with a randomly 
selected sample of patients who had self-
screened a normotensive result. Of these, 
five (17%) preferred an HCP to measure 
their BP and 11 (37%) preferred to self-
screen, primarily because of the improved 
convenience, with the remaining participants 
expressing no preference. Seven (23%) would 
have liked more privacy. The study did not 
report whether there were any differences in 
acceptability depending on the location of the 
self-screening equipment. Nor did it include 
people who had not screened.
In a linked study, it was found that the 
only BP self-screening opportunities 
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Background
Blood pressure (BP) self-screening, whereby 
members of the public have access to BP 
monitoring equipment outside of healthcare 
consultations, may increase the detection and 
treatment of hypertension. Currently in the UK 
such opportunities are largely confined to GP 
waiting rooms.
Aim
To investigate the reasons why people do or do 
not use BP self-screening facilities.
Design and setting
A cross-sectional, qualitative study in 
Oxfordshire, UK.
Method
Semi-structured interviews with members of 
the general public recruited using posters in 
GP surgeries and community locations were 
recorded, transcribed, and coded thematically.
Results
Of the 30 interviewees, 20% were hypertensive 
and almost half had self-screened. Those with 
no history of elevated readings had limited 
concern over their BP: self-screening filled the 
time waiting for their appointment or was done 
to help their doctor. Patients with hypertension 
self-screened to avoid the feelings they 
associated with ‘white coat syndrome’ and to 
introduce more control into the measurement 
process. Barriers to self-screening included a 
lack of awareness, uncertainty about technique, 
and worries over measuring BP in a public 
place. An unanticipated finding was that several 
interviewees preferred monitoring their BP in 
the waiting room than at home.
Conclusion
BP self-screening appeared acceptable to 
service users. Further promotion and education 
could increase awareness among non-users 
of the need for BP screening, the existence 
of self-screening facilities, and its ease of 
use. Waiting room monitors could provide an 
alternative for patients with hypertension who 
are unwilling or unable to monitor at home.
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routinely available to the general public in an 
English county were located in GP surgery 
waiting rooms.7 Such facilities are seen by 
primary care staff and GPs as a method of 
achieving BP screening performance targets 
and freeing up clinician time;7 however, 
little is known about how they are viewed 
by members of the public. The aim of the 
current study, therefore, was to investigate 
their reasons for using or not using such 
facilities to check their BP.
METHOD
Semi-structured qualitative interviews were 
conducted by a non-clinical researcher 
with members of the general public to 
gain an in-depth insight into their views 
and experiences of BP self-screening. 
Interviewees were recruited via posters 
displayed in three Oxfordshire GP surgeries 
with BP self-screening equipment, a library, 
and a community centre in Oxfordshire. 
An advert was also placed in an Oxford 
community newsletter and on their webpage. 
The posters and adverts invited adults (aged 
≥18 years) to contact the research team if 
they were willing to share their views and 
experiences, if any, of checking their BP in the 
community. The researcher then sent them a 
participant information sheet, consent form, 
and brief demographic survey for completion 
and return in a post-paid envelope if they 
were interested in participating. Recruitment 
continued until data saturation.16 Responders’ 
demographic details were monitored during 
recruitment to ensure a balance of ages, 
sexes, and self-screening experience. 
Interviewees were offered a £20 gift voucher 
as an acknowledgement of their time and 
reimbursed their travel expenses if attending 
the university for the interview.
An interview schedule was developed 
based on the study’s objectives and refined 
after initial use. Topics covered included 
knowledge and attitudes towards BP, 
whether they had self-screened, and the 
process of BP self-screening and other types 
of BP measurement. Interviews were digitally 
recorded, transcribed, and checked for 
accuracy. NVivo (QSR International, version 
9) was used to organise the transcripts 
and record the coding process. A coding 
framework was developed; initial coding 
was undertaken independently by two 
researchers. Codes used were refined using 
the constant comparison method.17 The One 
Sheet of Paper analysis method was used to 
compile all the issues raised for a single code 
and these were grouped to form themes.18 
The themes that emerged could be grouped 
into barriers and facilitators.
All interviewees gave written, informed 
consent before participation.
RESULTS
The planned sample size of 30 patients 
was interviewed: 15 (50%) were working, 
14 (47%) were female, and six (20%) were 
hypertensive (Table 1). It was felt that 
data saturation was achieved. Interviews 
were conducted on a 1:1 basis apart from 
a couple who requested to be interviewed 
together (BPSS111, BPSS112). For logistical 
reasons, one telephone interview and three 
interviews were conducted at interviewees’ 
homes rather than at the university. Box 1 
lists the abbreviations used to describe the 
interviewees.
Just under half (47%) had used a BP self-
screening facility at their own GP surgery. 
These were typically located in the waiting 
room or another public area of the building, 
such as a vestibule. Service users had 
mostly found the equipment simple to use 
and described self-screening to be a positive 
experience in the interview.
Below the interviewees’ reasons for and 
against checking their BP are described.
How this fits in
Blood pressure (BP) self-screening has 
been proposed as a way of increasing 
access to BP checks and reducing clinician 
workload. This study explores the reasons 
why patients used or did not use such 
facilities in GP waiting rooms. The findings 
will help general practices optimise the 
use and acceptability of BP monitors in 
their waiting room.
Table 1. Characteristics of interviewees, n = 30
  n %
BP self-screening service user  14 47
Hypertensive 6 20
Sex: female 14 47
Ethnic group: white 27 90
Age, years   
 <40 8 27 
 40–60 12 40 
 >60 10 33
Employment status 
 Working 15 50 
 Retired 7 23 
 Unable to work 2 7 
 Unemployed 3 10 
 Student 2 7 
 Home/family carer 1 3
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‘Cos it was there’
The main stimulus reported for using the 
equipment was observing it while waiting 
for their appointment with an HCP. There 
were few alternative activities with which to 
fill their time:
‘It’s either go and sit and read a magazine 
… or go and do something that might be 
beneficial for your health.’ (BPSS112, female 
[F], 25 years, used blood pressure self-
screening [BPSS], normotensive [NT, self-
reported])
Interviewees with no history of elevated 
readings had little concern about their BP. 
They self-screened to confirm their continued 
healthy status or used it as something to fill 
the time spent waiting:
‘It’s entertaining.’ (BPSS109, F, 50 years, used 
BPSS, NT)
Helping the doctor
There was a general feeling that checking 
their BP was a good thing and that the results 
were of use to HCPs, if not themselves. 
Asked why he had used the self-screening 
monitor while waiting for his appointment, 
one interviewee explained it was to assist his 
GP in making a diagnosis, that is:
‘To give the doctor as much information 
about me as possible.’ (BPSS101, male [M], 
57 years, used BPSS, NT)
BP self-screening was felt by patients to 
free up the time that would have otherwise 
been spent conducting the measurement in 
a time-restricted encounter:
‘If you’ve gone with a list of other things to 
be dealt with and it’s yet one more thing to 
add to the GP’s list, yet it’s a thing you can do 
yourself.’ (BPSS110, F, 52 years, used BPSS, 
NT)
Requesting a BP measurement from an 
HCP may trigger questioning, and if the 
result was normotensive this was interpreted 
as wasting the HCP’s time. Some patients, 
whose BP was being monitored because of 
potential side effects of their medication, for 
example, were asked by their GPs to use the 
equipment before their next appointment. 
Another interviewee’s GP noticed:
‘Oh we haven’t really checked everything 
over for lots of years, can you go and go 
on the weighing machine and the blood 
pressure machine and hand the tickets back 
into the receptionist?’ (BPSS107, F, 45 years, 
used BPSS, NT [patient here reporting the 
remarks of their GP]) 
The interviewee had previously used the 
BP machine out of curiosity but had not 
disclosed the result to her GP as it was not 
elevated.
Taking control
One key perceived benefit was the avoidance 
of the perceived white-coat effect (WCE),19 
especially among those with a self-reported 
history of elevated results:
‘Whoosh! It goes up because stupidly you get 
nervous, it’s silly.’ (BPSS104, F, 67 years, used 
BPSS, hypertensive [HT, self-reported])
During a consultation, the HCP controls 
the initiation of the BP measurement, 
interpreting and responding to the result:
‘When they say “Ah we’ll just do that again, 
just to make sure”, you think, “No it’s just 
because you can’t believe me reading.”’ 
(BPSS105, M, 58 years, used BPSS, HT)
In addition to being anxious about the 
result, some disliked the sensation of the cuff 
tightening:
‘My partner has a bit of white-coat syndrome 
and [by self-screening] he was trying 
to get into being comfortable using it and 
monitoring and just trying to de-sensitise 
himself.’ (BPSS109, F, 50 years, used BPSS, 
NT)
Service users felt empowered by being 
able to decide when and how often to check 
their BP:
‘I can just sort of walk in and do it without 
asking and that really helps.’ (BPSS122, F, 
46 years, used BPSS, NT)
Patients with hypertension, in particular, 
were able to manage what they disclosed to 
their HCP and what was recorded:
Box 1. Abbreviations used when describing interviewees
• M Male
• F Female
• Used BPSS Has self-screened using a waiting room blood pressure monitor
• Not used BPSS Has not self-screened using a waiting room blood pressure monitor
• HT Self-reported hypertension
• NT Self-reported normotension
BP = blood pressure.
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‘You can give it [the result] to the receptionist 
and they’ll enter it into your record if you want 
to or screw it up and not tell them if you think 
you’re stressed out.’ (BPSS122, F, 46 years, 
used BPSS, HT)
For those on the cusp of being diagnosed 
with hypertension, BP self-screening 
provided the opportunity to challenge the 
impending diagnosis:
‘Just give me a chance, I don’t want to take 
any medication yet because I just feel that 
I don’t have any blood pressure problem.’ 
(BPSS129, F, 35 years, BPSS user, NT)
A superior measurement over home 
monitoring BP?
An unanticipated finding was that several 
interviewees had discontinued home BP 
monitoring, preferring instead to use the 
waiting room machine. This was partly 
because of concerns about accuracy of home 
readings:
‘I prefer really to use the surgery one because 
I think in my head that that’s going to be 
more accurate.’ (BPSS104, F, 67 years, used 
BPSS, HT)
Fluctuations in home results were 
interpreted as being caused by deficiencies in 
their equipment or measurement technique:
‘I’m sure that it [the waiting room monitor] 
must be better than this sort of little piece 
of kit I bought on eBay for £10 or whatever I 
paid for it, you know, it looks a little bit more 
professional.’ (BPSS105, M, 58 years, used 
BPSS, HT)
Others did not want to introduce the 
negative feelings associated with BP 
measurement into their home or to facilitate 
excessive measurement:
‘The GP suggested that he [the interviewee’s 
partner] get a blood pressure machine of 
some sort for home use and we talked about 
that and weren’t quite sure that that was a 
good idea just because it could become even 
worse, just, you know, constantly checking 
and not having it [his BP] do what he wanted.’ 
(BPSS109, F, 50 years, used BPSS, NT)
In general, interviewees felt reassured 
by the robust monitor that they were not 
responsible for maintaining:
‘They wouldn’t have an inaccurate machine in 
a doctor’s surgery, I mean that’d be criminal 
really.’ (BPSS101, M, 57 years, used BPSS, NT)
The solid cuff in the surgery that did not 
require adjustment was also preferred:
‘It was easier to stick it in than to put a cuff 
on.’ (BPSS124, F, 84 years, used BPSS, HT)
Limited awareness of facilities
A key issue in using the equipment was 
knowing it was available. Promotion by GP 
practices varied:
‘It wasn’t pointed out that this machine was 
available, you just had to find out yourself.’ 
(BPSS101, M, 57 years, used BPSS, NT)
Infrequent attenders were unaware that 
the service was available, with several 
interviewees voicing reluctance to visit the 
GP:
‘I don’t tend to go to a GP ‘cos obviously I’m 
male and British so I’ll die first rather than 
go [laughs].’ (BPSS125, M, 50 years, not used 
BPSS, NT)
No need to check
Linked to the limited understanding of the 
asymptomatic nature of hypertension, some 
felt they would sense if something was amiss 
and therefore BP screening was not required:
‘I think I would know if it gets too high … I 
think if there was something wrong with my 
blood pressure I would be aware.’ (BPSS113, 
M, 67 years, not used BPSS, NT)
Regarding a friend who had been 
diagnosed with hypertension, one interviewee 
described how:
‘... there’s nothing wrong with the woman … 
she looks fit, healthy … she’s great … how 
can she be [hypertensive]?’ (BPSS127, F, 
79 years, used BPSS, NT)
Some were reluctant to use the self-
screening equipment because BP was not 
on their ‘agenda’ for attending the surgery:
‘She [interviewee’s mother] just thought it 
was pointless … I guess she just felt, feels 
healthy and … she wasn’t going to the doctor 
with concerns about her blood pressure.’ 
(BPSS112, F, 25 years, used BPSS, NT)
Female interviewees also described having 
their BP checked as part of their routine 
health care, reducing the need to check it 
themselves:
‘When you’re pregnant and that sort of thing 
you get your blood pressure taken a lot.’ 
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(BPSS107, F, 45 years, used BPSS, NT)
The job of a clinician
Although its novelty attracted some to use the 
monitor, its differing design from monitors 
used by HCPs or at home deterred others:
‘I didn’t know how the cuff was going to inflate 
or whether it was going to be painful or not.’ 
(BPSS111, M, 51 years, used BPSS, NT)
Others were concerned that a monitor 
designed for public use had been 
oversimplified and would produce poorer 
results than those suitable for expert use:
‘Our only association with blood pressure is a 
qualified health professional, often a doctor, 
doing it for you so you think if the doctor can 
only do that, I can’t.’ (BPSS125, M, 50 years, 
not used BPSS, NT)
Some doubted their ability to achieve a 
reliable BP result or interpret it correctly. One 
interviewee described how having her BP 
measured by a clinician was in itself healing:
‘There’s something quite kind of therapeutic 
about the healthcare professional putting on 
a blood pressure cuff, blowing it up, reading 
out the numbers, it just seems like kind of, I 
can’t really explain it … like the personal touch 
is really important.’ (BPSS116, F, 30 years, 
not used BPSS, NT)
Being on show
Being observed and having to remove outdoor 
clothing meant a minority of interviewees felt 
unable to use the self-screening equipment:
‘You have to get up and walk over the waiting 
room and perhaps take some of your clothes 
off, particularly if it’s the winter.’ (BPSS107, F, 
45 years, used BPSS, NT)
A younger interviewee was concerned it 
might highlight to others that she had an 
ongoing (unseen) health condition:
‘I think people might have thought I was just 
messing around if I’d come in to do it myself 
in the waiting room.’ (BPSS116, F, 30 years, 
not used BPSS, NT)
DISCUSSION
Summary
For those with no history of hypertension, 
the decision to check their BP was made 
lightly with little consideration of their 
susceptibility or any potential consequences. 
They self-screened to fill the time waiting 
for their appointment and to confirm 
their normotensive status. For patients 
with hypertension or those with a history 
of elevated results, the process was more 
considered. By self-screening, they gained 
control by deciding when they checked their 
BP and whether to disclose the results to 
their HCP.
Although BP self-screening removed 
the presence of an HCP, it introduced new 
anxieties associated with measuring BP in 
a public place, such as doubts about ability 
to use the equipment and about interpreting 
the results, which formed barriers to self-
screening.
Strengths and limitations
To the authors’ knowledge this is the first 
qualitative study investigating patient reasons 
for using public BP self-screening facilities. 
A recent systematic review of hypertension 
detection identified few existing studies that 
addressed barriers to attending screening, 
possibly because of the difficulty of conducting 
population-based research rather than using 
the ‘captive’ populations within hypertension 
clinics.20
Although the predominantly white sample 
reflects the ethnic make-up of Oxfordshire,21 
it limits the generalisability of the study 
findings to more diverse settings. Public BP 
measurement — including the removal of 
outer clothing — may be less acceptable 
in other cultural groups: the BP-Eth study, 
conducted in Birmingham (UK), found that 
people of South Asian and African Caribbean 
ethnic groups rated BP monitoring to be 
less acceptable than white English people.22 
This included ambulatory, office, and self-
monitoring measurements, although the 
acceptability of measurements taken in the 
waiting room was not studied.
The present sample included six self-
reported patients with hypertension and 
several more who described themselves as 
borderline. No interviewee had their first 
experience of an elevated reading using the 
waiting room monitor, however, and therefore 
future studies could explore the experience of 
self-screening triggering a change in BP 
status and the impact of not having an HCP 
present at this time.
Comparison with existing literature 
BP self-screening users accepted 
measurements taken in the waiting room 
as accurate, with some believing them to be 
superior to home readings, or free from the 
WCE. Although the diagnostic and prognostic 
accuracy of home BP measurements23–25 
and the phenomenon of the WCE26 are well 
characterised, the present authors are aware 
of only one study examining the accuracy of 
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BP measured in a waiting room.27 That study 
found such measures were comparable 
with the ‘gold standard’ of ambulatory BP 
measurements, but the results are of limited 
comparability with those of the current 
work as the previous study used a BpTRU 
device not a solid-cuff monitor that had been 
specifically designed for waiting room use. 
Another trial showed that regular use of self-
monitoring in the waiting room led to lower 
BP, at least in the short term.28
Those who rarely attended their surgery 
or were less engaged with their health were 
unaware of the availability of open-access 
BP monitors in their GP surgery. Several 
male interviewees expressed reluctance to 
attend their surgery. GP consultation rates 
are known to be higher in females than 
males, significantly so in younger adulthood 
(15–44 years).29 Meanwhile, national surveys 
have shown that, in those aged <70 years, 
hypertension is more prevalent in males than 
females,30 suggesting a mismatch between 
the need for screening and accessibility of 
waiting room BP monitors, which may have 
little promotion outside the GP practice.7
Some interviewees felt that self-screening 
was unnecessary as they would sense if their 
BP was elevated. The perceived symptomatic 
nature of hypertension has been reported 
elsewhere, as has the close link between 
elevated BP and stress.31 Among clinicians, 
BP is an accepted measure of cardiovascular 
health, but patients may be using self-
screening to monitor other parameters of 
their wellbeing such as their stress levels. 
The present findings also concur with a 
systematic review that concluded a lack of 
knowledge regarding the importance of BP 
screening and the potential consequences 
of hypertension were the most common 
barriers to hypertension detection.20
The present finding that some patients 
preferred to monitor their BP in the waiting 
room rather than in their own homes was 
unanticipated, partly because of the reduced 
convenience. This contrasts with an earlier 
survey of BP self-monitoring trial participants 
who preferred to monitor at home rather 
than in the waiting room.28 This variation in 
findings may result from differences between 
samples and, in practice, one mode of BP 
monitoring may not suit everyone.
Unlike BP measurements taken during 
consultations, self-screening introduces the 
opportunity for non-disclosure of results by 
patients to their HCPs. A similar phenomenon 
has also been observed in patients self-
monitoring their BP at home.32 Qualitative 
research found that this was because of 
perceived lack of interest from the clinician 
and fear of being prescribed additional 
medication.5 Using a waiting room monitor 
placed there by the HCPs may diminish the 
former reason for non-disclosure but HCPs 
should be aware that their patients may be 
checking their own BP in the waiting room 
and not telling them.
Implications for research and practice 
The present results suggest that general 
practices with BP monitors located in 
the waiting room may wish to consider 
the methods by which they promote their 
presence to patient groups who rarely attend 
primary care and/or infrequently have their 
BP measured. They should also reflect on 
their physical location within the practice to 
maximise acceptability to patients. Healthcare 
professionals should also be aware that 
patients may not report self-screened results 
unless they are directly asked or there is 
a clearly signposted system in place to 
encourage them to submit them for review.
Central to consolidating the role of waiting 
room monitors in primary care BP screening 
and hypertension management is confirming 
their utility. Monitors such as those in most 
waiting rooms have been clinically validated 
but no data currently exist to show that 
such equipment can lead to better rates of 
diagnosis or control.6–8 Waiting room monitors 
could then offer a halfway house for patients 
unwilling or unable to monitor at home and 
play a role in diagnostic and management 
pathways. Future research could evaluate 
interventions that seek to promote the use of 
BP self-screening monitors in clinics.
Given the finding that patients screen 
themselves to confirm their normotensive 
status, it would be helpful to investigate the 
impact of elevated self-screened results 
without an HCP on hand, perhaps using 
a ‘think aloud’ technique,33 in particular to 
better understand if and when patients decide 
to disclose such a result. This information 
would help to better characterise the utility of 
self-screening as a tool to reduce the burden 
of untreated hypertension, and the potential 
for community-based self-screening 
programmes.
The process of self-screening in the 
waiting room was generally well liked by 
service users. It is not currently accessed by 
all eligible patients, however, because of a 
lack of awareness about its existence or the 
perceived stigma of being seen (attempting) 
to measure BP. Several questions must be 
answered about BP self-screening in the 
relatively controlled environment of the 
waiting room before community BP self-
screening should be considered, especially 
in the face of the limited public demand 
reported in this study.
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